Table 3.
Median prices and Median Price Ratios of anti-malarials being sold in private and not-for-profit outlets
| |
Outlet type |
|||
|---|---|---|---|---|
|
Anti-malarials |
Private |
Not-for-profit |
||
| Median price (range) USD | Median price ratio | Median price (range) USD | Median price ratio | |
|
AL* |
0.94 (0.63-1.25) |
1.88 |
0.75 (0.63-1.00) |
1.5 |
|
Other forms of ACT** |
6.0 (1.88-10.63) |
12 |
2.5 (1.88-3.13) |
5 |
| Quinine* | 1.0 (0.75-1.25) | 1.33 | 0.75 (0.63-1.13) | 1 |
USD, United States Dollars; ACT, artemisinin-based combination therapy; AL, artemether-lumefantrine.
*Median price ratio was calculated using median price of quinine in not-for-profit as reference since there is no government subsidized price.
**Median price ratio was calculated as anti-malarial median price to the government recommended price of subsidized ACT (AL) (KES 40, USD 0.5).